JP2010528053A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010528053A5 JP2010528053A5 JP2010509585A JP2010509585A JP2010528053A5 JP 2010528053 A5 JP2010528053 A5 JP 2010528053A5 JP 2010509585 A JP2010509585 A JP 2010509585A JP 2010509585 A JP2010509585 A JP 2010509585A JP 2010528053 A5 JP2010528053 A5 JP 2010528053A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteamine
- influenza
- subject
- group
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94025507P | 2007-05-25 | 2007-05-25 | |
| PCT/US2008/064860 WO2009023356A2 (en) | 2007-05-25 | 2008-05-27 | Materials and methods for treating influenza infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010528053A JP2010528053A (ja) | 2010-08-19 |
| JP2010528053A5 true JP2010528053A5 (enExample) | 2012-07-12 |
Family
ID=40351396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509585A Pending JP2010528053A (ja) | 2007-05-25 | 2008-05-27 | インフルエンザ感染症を治療するための物質および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100151042A1 (enExample) |
| JP (1) | JP2010528053A (enExample) |
| CN (1) | CN101842092A (enExample) |
| WO (1) | WO2009023356A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0905451D0 (en) * | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
| DK2521554T3 (en) * | 2009-12-30 | 2018-02-26 | Bagi Res Limited | MATERIALS AND PROCEDURES FOR PREVENTING AND TREATING VIRAL INFECTIONS |
| GB201611712D0 (en) | 2016-07-02 | 2016-08-17 | Hvivo Services Ltd | Methods and compounds for the treatment or prevention of severe or persistent influenza |
| GB201721793D0 (en) | 2017-12-22 | 2018-02-07 | Hvivo Services Ltd | Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza |
| CN114340637A (zh) * | 2019-07-03 | 2022-04-12 | 阿伊里斯株式会社 | 用于治疗流感病毒感染症的药物组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554655A (en) * | 1991-09-30 | 1996-09-10 | Jess G. Thoene | Method of treating HIV infection |
| US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| WO2006091610A2 (en) * | 2005-02-23 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Inhibitors of enveloped virus infectivity |
| AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
-
2008
- 2008-05-27 WO PCT/US2008/064860 patent/WO2009023356A2/en not_active Ceased
- 2008-05-27 US US12/600,264 patent/US20100151042A1/en not_active Abandoned
- 2008-05-27 CN CN200880021533A patent/CN101842092A/zh active Pending
- 2008-05-27 JP JP2010509585A patent/JP2010528053A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7019727B2 (ja) | インフルエンザの治療方法 | |
| US9283198B2 (en) | Materials and methods for treating viral infections | |
| JP2010528053A5 (enExample) | ||
| WO2017004499A1 (en) | Compositions and methods for the treatment of viral infection | |
| US20100151042A1 (en) | Materials and Methods for Treating Influenza Infections | |
| WO2022150709A1 (en) | Compositions and methods for treating viral infection | |
| JP6195902B2 (ja) | ウイルス感染症の予防および治療のための材料および方法 | |
| US20220218668A1 (en) | Compositions and methods for treating viral infection | |
| RU2431476C2 (ru) | Материалы и способы лечения вирусных инфекций с помощью соединения цистеамина | |
| Hoopes et al. | Evaluation of the Contribution of Amantadine, Ribavirin, and Oseltamivir in a Triple Combination Antiviral Drug (TCAD) Regimen to Suppressing the Emergence of Resistance using a Novel Quantitative Approach | |
| NZ755900B2 (en) | Methods of treating influenza | |
| HK1123726B (en) | Materials and methods for treating viral infections with a cysteamine compound |